These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20714644)

  • 1. Coevolution of PDZ domain-ligand interactions analyzed by high-throughput phage display and deep sequencing.
    Ernst A; Gfeller D; Kan Z; Seshagiri S; Kim PM; Bader GD; Sidhu SS
    Mol Biosyst; 2010 Oct; 6(10):1782-90. PubMed ID: 20714644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.
    Wiedemann U; Boisguerin P; Leben R; Leitner D; Krause G; Moelling K; Volkmer-Engert R; Oschkinat H
    J Mol Biol; 2004 Oct; 343(3):703-18. PubMed ID: 15465056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and screening of support-bound combinatorial peptide libraries with free C-termini: determination of the sequence specificity of PDZ domains.
    Joo SH; Pei D
    Biochemistry; 2008 Mar; 47(9):3061-72. PubMed ID: 18232644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degenerate specificity of PDZ domains from RhoA-specific nucleotide exchange factors PDZRhoGEF and LARG.
    Smietana K; Kasztura M; Paduch M; Derewenda U; Derewenda ZS; Otlewski J
    Acta Biochim Pol; 2008; 55(2):269-80. PubMed ID: 18542831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering and analysis of peptide-recognition domain specificities by phage display and deep sequencing.
    McLaughlin ME; Sidhu SS
    Methods Enzymol; 2013; 523():327-49. PubMed ID: 23422437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An allosteric intramolecular PDZ-PDZ interaction modulates PTP-BL PDZ2 binding specificity.
    van den Berk LC; Landi E; Walma T; Vuister GW; Dente L; Hendriks WJ
    Biochemistry; 2007 Nov; 46(47):13629-37. PubMed ID: 17979300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary expansion and specialization of the PDZ domains.
    Sakarya O; Conaco C; Egecioglu O; Solla SA; Oakley TH; Kosik KS
    Mol Biol Evol; 2010 May; 27(5):1058-69. PubMed ID: 20026484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based prediction of the peptide sequence space recognized by natural and synthetic PDZ domains.
    Smith CA; Kortemme T
    J Mol Biol; 2010 Sep; 402(2):460-74. PubMed ID: 20654621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
    Hou T; Zhang W; Case DA; Wang W
    J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage display: concept, innovations, applications and future.
    Pande J; Szewczyk MM; Grover AK
    Biotechnol Adv; 2010; 28(6):849-58. PubMed ID: 20659548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving specificity from variability for protein interaction domains.
    Kaneko T; Sidhu SS; Li SS
    Trends Biochem Sci; 2011 Apr; 36(4):183-90. PubMed ID: 21227701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential determination of ligands binding to discrete components in heterogeneous mixtures by iterative panning and blocking (IPAB).
    Messmer BT; Benham CJ; Thaler DS
    J Mol Biol; 2000 Feb; 296(3):821-32. PubMed ID: 10677284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain Interaction Footprint: a multi-classification approach to predict domain-peptide interactions.
    Schillinger C; Boisguerin P; Krause G
    Bioinformatics; 2009 Jul; 25(13):1632-9. PubMed ID: 19376827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing scaffolds of peptides for phage display libraries.
    Uchiyama F; Tanaka Y; Minari Y; Tokui N
    J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed evolution of PDZ variants to generate high-affinity detection reagents.
    Ferrer M; Maiolo J; Kratz P; Jackowski JL; Murphy DJ; Delagrave S; Inglese J
    Protein Eng Des Sel; 2005 Apr; 18(4):165-73. PubMed ID: 15820976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Assessment of the Relationship Between Site
    Teyra J; McLaughlin M; Singer A; Kelil A; Ernst A; Sicheri F; Sidhu SS
    J Mol Biol; 2021 Sep; 433(18):167115. PubMed ID: 34171344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of the binding preferences of peptide recognition modules: SH3 and PDZ domains.
    Teyra J; Sidhu SS; Kim PM
    FEBS Lett; 2012 Aug; 586(17):2631-7. PubMed ID: 22691579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity selective isolation of ligands from peptide libraries through display on a lac repressor "headpiece dimer".
    Gates CM; Stemmer WP; Kaptein R; Schatz PJ
    J Mol Biol; 1996 Jan; 255(3):373-86. PubMed ID: 8568883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into human Lck SH3 domain binding specificity: different binding modes of artificial and native ligands.
    Tran T; Hoffmann S; Wiesehan K; Jonas E; Luge C; Aladag A; Willbold D
    Biochemistry; 2005 Nov; 44(45):15042-52. PubMed ID: 16274251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation and evolution in and among SRF- and MEF2-type MADS domains and their binding sites.
    Wu W; Huang X; Cheng J; Li Z; de Folter S; Huang Z; Jiang X; Pang H; Tao S
    Mol Biol Evol; 2011 Jan; 28(1):501-11. PubMed ID: 20724380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.